Tag: cell transfection market trends

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Cell Transfection Market Expected To Reach $2.17 Billion By 2030 At 8.9% CAGR

The market for cell transfection witnessed robust expansion recently, projected to climb from $1.42 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 9.2%. This surge in demand during the past period is linked to several key factors, including the broadening scope of molecular biology research, a greater reliance on gene expression studies, advancements in recombinant protein production, the escalating application of in vitro genetic manipulation techniques, and the availability of a wide array of transfection methodologies.

The cell transfection market is poised for substantial expansion over the coming years, projecting a valuation of $2.17 billion by 2030, driven by an 8.9% compound annual growth rate. This anticipated growth trajectory is fueled by several key factors, including the burgeoning development of gene and cell therapies, increased financial commitment to genetic engineering research, a heightened demand for high-throughput screening methodologies, the broadening scope of personalized medicine initiatives, and the expanding utilization of non-viral delivery systems. Several significant trends are expected to shape this market during the forecast period, such as a greater embrace of highly effective transfection reagents, a rise in the application of viral vector-based transfection techniques, burgeoning demand for transfection methods that can be scaled up, the proliferation of automated transfection platforms, and a heightened emphasis on ensuring the reproducibility of transfection processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Cell Transfection Market Industry Drivers: What Is Driving Revenue Growth?

The rising incidence of infectious diseases is anticipated to significantly boost the cell transfection market’s expansion. Infectious diseases, characterized by their transmission through various means, have seen an upsurge due to factors like underdeveloped public health systems, vaccine reluctance, and the proliferation of false information, which collectively enable pathogen dissemination and mutation. Cell transfection serves as an invaluable method in combating infectious diseases by enabling researchers to introduce genetic material into cells for the purpose of understanding infection mechanisms and evaluating novel therapeutic strategies. For example, as reported by the World Health Organization, a global public health entity based in Switzerland, approximately 8.2 million new tuberculosis diagnoses occurred in 2023, an increase from the roughly 7.5 million cases identified in 2022, underscoring tuberculosis’s position as the foremost cause of infectious disease mortality. Consequently, the escalating prevalence of infectious diseases is a key driver for the cell transfection market.

Cell Transfection Market Segmentation And Category Breakdown

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

#Cell Transfection Market Growth Trends: What Is Influencing The Future Outlook?

Leading entities within the cell transfection sector are actively incorporating novel advancements into their transfection methodologies to facilitate meticulous regulation of genetic expression. Essentially, a transfection system represents a method or apparatus developed for the purpose of inserting exogenous nucleic acids into cellular structures, thereby facilitating the investigation of gene roles, the synthesis of proteins, or the modification of gene activity. As an illustration, during July of 2024, STEMCELL Technologies, a prominent biotechnology firm headquartered in Canada, introduced its Cellpore transfection system. This innovative instrument is engineered to bolster research endeavors in cell engineering. Leveraging cutting-edge microfluidic technology, the system streamlines the intracellular introduction of a wide spectrum of macromolecules into cells, effectively overcoming the shortcomings inherent in conventional transfection approaches. Its capacity to transfect as many as ten million cells each second renders it highly advantageous for operations requiring significant throughput. Furthermore, the system demonstrates versatility across a range of cell populations, including but not limited to T cells and hematopoietic stem cells. It possesses the capability to deliver a variety of payload types, encompassing small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Cell Transfection Market Competitive Analysis Of Major Industry Participants

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Cell Transfection Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the cell transfection market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Cell Transfection Market Expected To Reach $2.17 Billion By 2030 At 8.9% CAGR

The market for cell transfection witnessed robust expansion recently, projected to climb from $1.42 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 9.2%. This surge in demand during the past period is linked to several key factors, including the broadening scope of molecular biology research, a greater reliance on gene expression studies, advancements in recombinant protein production, the escalating application of in vitro genetic manipulation techniques, and the availability of a wide array of transfection methodologies.

The cell transfection market is poised for substantial expansion over the coming years, projecting a valuation of $2.17 billion by 2030, driven by an 8.9% compound annual growth rate. This anticipated growth trajectory is fueled by several key factors, including the burgeoning development of gene and cell therapies, increased financial commitment to genetic engineering research, a heightened demand for high-throughput screening methodologies, the broadening scope of personalized medicine initiatives, and the expanding utilization of non-viral delivery systems. Several significant trends are expected to shape this market during the forecast period, such as a greater embrace of highly effective transfection reagents, a rise in the application of viral vector-based transfection techniques, burgeoning demand for transfection methods that can be scaled up, the proliferation of automated transfection platforms, and a heightened emphasis on ensuring the reproducibility of transfection processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Cell Transfection Market Industry Drivers: What Is Driving Revenue Growth?

The rising incidence of infectious diseases is anticipated to significantly boost the cell transfection market’s expansion. Infectious diseases, characterized by their transmission through various means, have seen an upsurge due to factors like underdeveloped public health systems, vaccine reluctance, and the proliferation of false information, which collectively enable pathogen dissemination and mutation. Cell transfection serves as an invaluable method in combating infectious diseases by enabling researchers to introduce genetic material into cells for the purpose of understanding infection mechanisms and evaluating novel therapeutic strategies. For example, as reported by the World Health Organization, a global public health entity based in Switzerland, approximately 8.2 million new tuberculosis diagnoses occurred in 2023, an increase from the roughly 7.5 million cases identified in 2022, underscoring tuberculosis’s position as the foremost cause of infectious disease mortality. Consequently, the escalating prevalence of infectious diseases is a key driver for the cell transfection market.

Cell Transfection Market Segmentation And Category Breakdown

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

#Cell Transfection Market Growth Trends: What Is Influencing The Future Outlook?

Leading entities within the cell transfection sector are actively incorporating novel advancements into their transfection methodologies to facilitate meticulous regulation of genetic expression. Essentially, a transfection system represents a method or apparatus developed for the purpose of inserting exogenous nucleic acids into cellular structures, thereby facilitating the investigation of gene roles, the synthesis of proteins, or the modification of gene activity. As an illustration, during July of 2024, STEMCELL Technologies, a prominent biotechnology firm headquartered in Canada, introduced its Cellpore transfection system. This innovative instrument is engineered to bolster research endeavors in cell engineering. Leveraging cutting-edge microfluidic technology, the system streamlines the intracellular introduction of a wide spectrum of macromolecules into cells, effectively overcoming the shortcomings inherent in conventional transfection approaches. Its capacity to transfect as many as ten million cells each second renders it highly advantageous for operations requiring significant throughput. Furthermore, the system demonstrates versatility across a range of cell populations, including but not limited to T cells and hematopoietic stem cells. It possesses the capability to deliver a variety of payload types, encompassing small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Cell Transfection Market Competitive Analysis Of Major Industry Participants

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Cell Transfection Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the cell transfection market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Cell Transfection Market Expected To Reach $2.17 Billion By 2030 At 8.9% CAGR

The market for cell transfection witnessed robust expansion recently, projected to climb from $1.42 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate of 9.2%. This surge in demand during the past period is linked to several key factors, including the broadening scope of molecular biology research, a greater reliance on gene expression studies, advancements in recombinant protein production, the escalating application of in vitro genetic manipulation techniques, and the availability of a wide array of transfection methodologies.

The cell transfection market is poised for substantial expansion over the coming years, projecting a valuation of $2.17 billion by 2030, driven by an 8.9% compound annual growth rate. This anticipated growth trajectory is fueled by several key factors, including the burgeoning development of gene and cell therapies, increased financial commitment to genetic engineering research, a heightened demand for high-throughput screening methodologies, the broadening scope of personalized medicine initiatives, and the expanding utilization of non-viral delivery systems. Several significant trends are expected to shape this market during the forecast period, such as a greater embrace of highly effective transfection reagents, a rise in the application of viral vector-based transfection techniques, burgeoning demand for transfection methods that can be scaled up, the proliferation of automated transfection platforms, and a heightened emphasis on ensuring the reproducibility of transfection processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Cell Transfection Market Industry Drivers: What Is Driving Revenue Growth?

The rising incidence of infectious diseases is anticipated to significantly boost the cell transfection market’s expansion. Infectious diseases, characterized by their transmission through various means, have seen an upsurge due to factors like underdeveloped public health systems, vaccine reluctance, and the proliferation of false information, which collectively enable pathogen dissemination and mutation. Cell transfection serves as an invaluable method in combating infectious diseases by enabling researchers to introduce genetic material into cells for the purpose of understanding infection mechanisms and evaluating novel therapeutic strategies. For example, as reported by the World Health Organization, a global public health entity based in Switzerland, approximately 8.2 million new tuberculosis diagnoses occurred in 2023, an increase from the roughly 7.5 million cases identified in 2022, underscoring tuberculosis’s position as the foremost cause of infectious disease mortality. Consequently, the escalating prevalence of infectious diseases is a key driver for the cell transfection market.

Cell Transfection Market Segmentation And Category Breakdown

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

#Cell Transfection Market Growth Trends: What Is Influencing The Future Outlook?

Leading entities within the cell transfection sector are actively incorporating novel advancements into their transfection methodologies to facilitate meticulous regulation of genetic expression. Essentially, a transfection system represents a method or apparatus developed for the purpose of inserting exogenous nucleic acids into cellular structures, thereby facilitating the investigation of gene roles, the synthesis of proteins, or the modification of gene activity. As an illustration, during July of 2024, STEMCELL Technologies, a prominent biotechnology firm headquartered in Canada, introduced its Cellpore transfection system. This innovative instrument is engineered to bolster research endeavors in cell engineering. Leveraging cutting-edge microfluidic technology, the system streamlines the intracellular introduction of a wide spectrum of macromolecules into cells, effectively overcoming the shortcomings inherent in conventional transfection approaches. Its capacity to transfect as many as ten million cells each second renders it highly advantageous for operations requiring significant throughput. Furthermore, the system demonstrates versatility across a range of cell populations, including but not limited to T cells and hematopoietic stem cells. It possesses the capability to deliver a variety of payload types, encompassing small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Cell Transfection Market Competitive Analysis Of Major Industry Participants

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Cell Transfection Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the cell transfection market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Cell Transfection Market Change Between 2026 And 2030?

The market for cell viability assays has expanded significantly in recent years. It is projected to grow from $1.73 billion in 2025 to $1.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. Historically, this expansion has been driven by factors such as the increasing scope of in vitro research activities, greater spending on pharmaceutical R&D, an uptick in toxicology testing, the growing adoption of cell culture models, and the widespread availability of standardized assay kits.

The cell viability assays market size is projected to experience substantial growth over the next few years. It is anticipated to reach $2.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is primarily driven by factors such as the increasing need for high-throughput drug discovery, the rising use of automated assay platforms, the broadening scope of personalized medicine research, an intensifying focus on assay miniaturization, and the growing incorporation of imaging-based viability analysis. Key trends expected within this period involve the increasing uptake of high-sensitivity viability assays, a growing reliance on microplate-based detection systems, an expanding requirement for multiparametric cell health analysis, the proliferation of drug screening applications, and an elevated emphasis on reproducible assay protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Factors Are Strengthening The Cell Transfection Market Landscape?

The rising prevalence of cell-based therapeutics is projected to fuel the expansion of the cell viability assay market moving forward. Cell-based therapeutics refer to medical interventions that utilize living cells to repair or replace damaged tissue, address diseases, or restore normal functionality. The advancement of these therapeutics is propelled by breakthroughs in biotechnology, increased investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays are vital for supporting cell-based therapeutics by ensuring the health, functionality, and safety of the therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, in 2023, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials experienced a 10% increase in Q3 2023, marking the first quarterly rise since Q3 2022. Therefore, the growth in cell-based therapeutics is significantly driving the cell viability assay market’s growth.

Which Segment Groups Define The Cell Transfection Market Landscape?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Influencing The Cell Transfection Market Outlook?

Leading companies in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. These cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thereby optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform designed for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging capabilities with both brightfield and fluorescent channels. Its AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research across biomedical and life science applications.

Who Are The Businesses Driving Activity In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Access The Complete Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Which Region Has The Strongest Presence In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Transfection Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Cell Transfection Market Expected To Scale Between 2026 And 2030?

The cell transfection market size has experienced significant growth recently. It is projected to increase from $1.42 billion in 2025 to $1.55 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. The market’s past expansion can be attributed to the growth of molecular biology research, the wider application of gene expression studies, an uptick in recombinant protein production, the rising acceptance of in vitro genetic manipulation, and the availability of varied transfection techniques.

The cell transfection market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. Key factors contributing to this growth during the forecast period include the accelerated development of gene and cell therapies, increased investments in genetic engineering research, an escalating demand for high-throughput screening assays, the broadening scope of personalized medicine research, and the expanding utilization of non-viral delivery technologies. Prominent trends identified for the forecast period encompass a greater uptake of high-efficiency transfection reagents, a surge in the application of viral vector-based transfection, an increasing need for scalable transfection methodologies, the proliferation of automated transfection platforms, and a heightened emphasis on ensuring transfection reproducibility.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Which Key Factors Are Driving The Cell Transfection Market Growth?

The growing incidence of infectious diseases is anticipated to propel the cell transfection market forward. Infectious diseases are conditions caused by germs that can spread between people or through contaminated sources. The spread and evolution of pathogens have been aided by inadequate public health infrastructure, alongside vaccine hesitancy and the dissemination of misinformation. Cell transfection acts as a vital tool in combating infectious diseases, as it allows scientists to introduce genes into cells to study infection mechanisms and test potential new treatments. For instance, in October 2024, the World Health Organization, an international public health organization based in Switzerland, reported approximately 8.2 million new tuberculosis diagnoses in 2023, an increase from about 7.5 million in 2022, thus ranking tuberculosis as the leading infectious disease killer. Consequently, the rising number of infectious disease cases is a key driver for the cell transfection market.

What Are The Main Segments Within The Cell Transfection Market Segment Structure?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

Which Trends Are Guiding The Direction Of The Cell Transfection Market?

Leading companies within the cell transfection market are incorporating innovations into transfection systems to achieve precise control over gene expression. A transfection system represents a method or technology developed to introduce foreign nucleic acids into cells for studying gene function, producing proteins, or altering gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, introduced its Cellpore transfection system. This novel tool is designed to advance cell engineering research. The system leverages sophisticated microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, thereby overcoming the limitations of traditional transfection methods. It boasts the ability to transfect up to 10 million cells per second, rendering it appropriate for large-scale applications. The system demonstrates compatibility with diverse cell types, including T cells and hematopoietic stem cells, and is capable of delivering various cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Who Are The Companies Participating In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Get The Full Cell Transfection Market Report:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Which Region Has The Greatest Market Share In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Transfection Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cell And Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cell Transfection Market In 2026 And What Value Is Projected For 2030?

The cell transfection market size has demonstrated significant growth over recent years. It is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be attributed to several factors including the broadening of molecular biology research, the increased utilization of gene expression studies, the rise in recombinant protein production, the growing adoption of in vitro genetic manipulation, and the availability of a variety of transfection methods.

The cell transfection market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This predicted growth stems from factors such as the accelerated development of gene and cell therapies, increased investments in genetic engineering research, a rising demand for high-throughput screening assays, the expansion of personalized medicine research, and the increasing adoption of non-viral delivery technologies. Key trends anticipated during this period encompass the greater adoption of high-efficiency transfection reagents, an increase in the use of viral vector-based transfection, a growing need for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cell Transfection Market?

The increasing incidence of infectious diseases is projected to drive the future growth of the cell transfection market. Infectious diseases are illnesses stemming from germs that disseminate from person to person or via contaminated sources. Inadequate public health infrastructure, along with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to investigate how infections affect them and to evaluate new treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, roughly 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the rise in infectious disease cases propels the cell transfection market.

What Are The Key Segments Of The Cell Transfection Market?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Projected To Affect The Cell Transfection Market?

Major companies operating in the cell transfection market are actively integrating innovations into their transfection systems to enable precise control over gene expression. A transfection system is a technique or technology specifically designed to introduce foreign nucleic acids into cells, serving purposes like studying gene function, producing proteins, or altering gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system, a novel tool engineered to enhance cell engineering research. This system leverages advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, thereby addressing limitations associated with traditional transfection methods. It possesses the capability to transfect up to 10 million cells per second, rendering it suitable for large-scale applications. Moreover, the system demonstrates compatibility with diverse cell types, including T cells and hematopoietic stem cells, and can effectively deliver various cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Who Are The Leading Companies Operating In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Read the full cell transfection market report here:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

What Are The Leading Geographic Regions In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Transfection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cell Transfection Market In 2026 And What Value Is Projected For 2030?

The cell transfection market size has demonstrated significant growth over recent years. It is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be attributed to several factors including the broadening of molecular biology research, the increased utilization of gene expression studies, the rise in recombinant protein production, the growing adoption of in vitro genetic manipulation, and the availability of a variety of transfection methods.

The cell transfection market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This predicted growth stems from factors such as the accelerated development of gene and cell therapies, increased investments in genetic engineering research, a rising demand for high-throughput screening assays, the expansion of personalized medicine research, and the increasing adoption of non-viral delivery technologies. Key trends anticipated during this period encompass the greater adoption of high-efficiency transfection reagents, an increase in the use of viral vector-based transfection, a growing need for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cell Transfection Market?

The increasing incidence of infectious diseases is projected to drive the future growth of the cell transfection market. Infectious diseases are illnesses stemming from germs that disseminate from person to person or via contaminated sources. Inadequate public health infrastructure, along with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to investigate how infections affect them and to evaluate new treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, roughly 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the rise in infectious disease cases propels the cell transfection market.

What Are The Key Segments Of The Cell Transfection Market?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Projected To Affect The Cell Transfection Market?

Major companies operating in the cell transfection market are actively integrating innovations into their transfection systems to enable precise control over gene expression. A transfection system is a technique or technology specifically designed to introduce foreign nucleic acids into cells, serving purposes like studying gene function, producing proteins, or altering gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system, a novel tool engineered to enhance cell engineering research. This system leverages advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, thereby addressing limitations associated with traditional transfection methods. It possesses the capability to transfect up to 10 million cells per second, rendering it suitable for large-scale applications. Moreover, the system demonstrates compatibility with diverse cell types, including T cells and hematopoietic stem cells, and can effectively deliver various cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Who Are The Leading Companies Operating In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Read the full cell transfection market report here:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

What Are The Leading Geographic Regions In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Transfection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Cell Transfection Market In 2026 And What Value Is Projected For 2030?

The cell transfection market size has demonstrated significant growth over recent years. It is anticipated to expand from $1.42 billion in 2025 to $1.55 billion in 2026, driven by a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be attributed to several factors including the broadening of molecular biology research, the increased utilization of gene expression studies, the rise in recombinant protein production, the growing adoption of in vitro genetic manipulation, and the availability of a variety of transfection methods.

The cell transfection market is anticipated to experience robust expansion over the coming years. This market is projected to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This predicted growth stems from factors such as the accelerated development of gene and cell therapies, increased investments in genetic engineering research, a rising demand for high-throughput screening assays, the expansion of personalized medicine research, and the increasing adoption of non-viral delivery technologies. Key trends anticipated during this period encompass the greater adoption of high-efficiency transfection reagents, an increase in the use of viral vector-based transfection, a growing need for scalable transfection methods, the expansion of automated transfection platforms, and a heightened emphasis on transfection reproducibility.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Cell Transfection Market?

The increasing incidence of infectious diseases is projected to drive the future growth of the cell transfection market. Infectious diseases are illnesses stemming from germs that disseminate from person to person or via contaminated sources. Inadequate public health infrastructure, along with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection serves as a potent tool for infectious diseases, enabling scientists to introduce genes into cells to investigate how infections affect them and to evaluate new treatments. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, roughly 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, identifying tuberculosis as the leading infectious disease killer. Consequently, the rise in infectious disease cases propels the cell transfection market.

What Are The Key Segments Of The Cell Transfection Market?

The cell transfection market covered in this report is segmented –

1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods

2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production

3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation

2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection

3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods

4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction

5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection

What Trends Are Projected To Affect The Cell Transfection Market?

Major companies operating in the cell transfection market are actively integrating innovations into their transfection systems to enable precise control over gene expression. A transfection system is a technique or technology specifically designed to introduce foreign nucleic acids into cells, serving purposes like studying gene function, producing proteins, or altering gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system, a novel tool engineered to enhance cell engineering research. This system leverages advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, thereby addressing limitations associated with traditional transfection methods. It possesses the capability to transfect up to 10 million cells per second, rendering it suitable for large-scale applications. Moreover, the system demonstrates compatibility with diverse cell types, including T cells and hematopoietic stem cells, and can effectively deliver various cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.

Who Are The Leading Companies Operating In The Cell Transfection Market?

Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.

Read the full cell transfection market report here:

https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report

What Are The Leading Geographic Regions In The Cell Transfection Market?

North America was the largest region in the cell transfection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Transfection Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19361&type=smp

Browse Through More Reports Similar to the Global Cell Transfection Market 2026, By The Business Research Company

Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Human Raw Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model